Vyndaqel, can keep TTR from separating and framing amyloid stores. This prescription is utilized to treat grown-up patients with this infection whose nerves have been influenced (individuals with symptomatic polyneuropathy).
Vyndaqel is a medicine which treats a disease called Transthyretin (TTR) amyloid polyneuropathy, also known as TTR familial amyloid polyneuropathy (TTR-FAP). TTR amyloid polyneuropathy is caused by a protein called TTR that does not work properly. TTR is an important protein that carries other substances, such as hormones, through the body.
In patients with this disease, TTR breaks up and may form fibers called amyloid. Amyloid can build up around your nerves and in other places in your body, preventing them from working normally. Eventually, the amyloid causes the symptoms of this disease.
Vyndaqel, can prevent TTR from breaking up and forming amyloid deposits. This medicine is used to treat adult patients with this disease whose nerves have been affected (people with symptomatic
The most common side effects were urinary tract infection, vaginal infection, diarrhea and upper abdominal pain.